Increasing brain acidity may slow down anxiety

Image
IANS Washington
Last Updated : Feb 26 2014 | 10:50 AM IST

Suffering from anxiety and related problems? Scientists have found a new target to treat anxiety disorder.

Increasing acidity in the brain's emotional control centre can reduce anxiety, according to a new research.

At the cellular level, anxiety disorders are associated with heightened activity in the basolateral amygdala (BLA) in the brain which is known to play a central role in emotional behaviour.

Many cells in the BLA possess acid-sensing ion channels called 'ASIC1a' that respond to pH changes in the environment outside of the cell.

Maria Braga and colleagues at the Uniformed Services University of the Health Sciences - a health science university run by the US federal government - found that activating 'ASIC1a' decreased the activity of nearby cells and reduced anxiety-like behaviour in animals.

"It suggests that activating these channels, specifically in fear-related areas such as the amygdala, may be a key to regulating anxiety," explained Anantha Shekhar from Indiana University who was not involved in this study.

"Developing specific drugs that can stimulate these channels could provide a new way to treat anxiety and fear disorders such a post-traumatic stress and panic disorders," she stated.

To determine the effect, Braga's group bathed BLA cells in an acidic solution in the laboratory and measured the signals sent to nearby cells.

Lowering the pH of the solution decreased the activity of cells in the BLA.

When rats received a drug designed to increase the activity of ASIC1a channels, the animals displayed less anxiety-like behaviour.

"Our study emphasises the importance of identifying mechanisms involved in the regulation of brain function for the development of more efficacious therapies for treating psychiatric and neurological illnesses," Braga noted.

Anxiety disorders, which are characterised by an inability to control feelings of fear and uncertainty, are the most prevalent group of psychiatric diseases, concluded the study published in the Journal of Neuroscience.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 26 2014 | 10:46 AM IST

Next Story